Mode of action of antirheumatic drugs.
The concentrations of free and protein-bound L-tryptophan were measured in sera from normal subjects, patients with rheumatoid arthritis, pregnant women, and patients with jaundice. In the patients with rheumatoid arthritis receiving treatment with one or more antirheumatic drugs the percentage of the amino-acid bound to the circulating proteins was significantly depressed and in one patient returned to normal when therapy was stopped. Pregnancy and jaundice were also associated with raised free tryptophan and decreased bound tryptophan concentrations and bilirubin displaced the amino-acid from its binding sites on human serum proteins in vitro. It is suggested the behaviour of tryptophan mimics that of certain peptides which protect susceptible tissues against chronic inflammatory insults.
D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy*; D001241:Aspirin / Q000627:therapeutic use; D001663:Bilirubin / Q000378:metabolism; D001665:Binding Sites; D001798:Blood Proteins; D002738:Chloroquine / Q000627:therapeutic use; D005260:Female; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007565:Jaundice / Q000097:blood; D008297:Male; D008875:Middle Aged; D010653:Phenylbutazone / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011247:Pregnancy; D011485:Protein Binding; D014364:Tryptophan / Q000097:blood
D001798:Blood Proteins; D006046:Gold; D002738:Chloroquine; D014364:Tryptophan; D011239:Prednisolone; D010653:Phenylbutazone; D001241:Aspirin; D001663:Bilirubin; D007213:Indomethacin